p.64 抽出テキスト

210. Mizuno Y, Hokimoto S, Harada E, et al. Variant Aldehyde Dehydrogenase 2 (ALDH2*2) in East Asians Interactively Exacerbates Tobacco Smoking Risk for Coronary Spas ― Possible Role of Reactive Aldehydes. Circ J 2016; 81: 96-102. PMID: 27904031 211. Daiber A, Oelze M, Wenzel P, et al. Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacol Rep 2009; 61: 33-48. PMID: 19307691 212. Takahashi J, Nihei T, Takagi Y, et al. Japanese Coronary Spasm Association. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J 2015; 36: 228-237. PMID: 25189599 213. Mizuno Y, Harada E, Kugimiya F, et al. East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina. Circ J 2020; 84: 479-486. PMID: 32009064 214. Morikawa Y, Mizuno Y, Harada E, et al. Nitrate tolerance as a possible cause of multidrug-resistant coronary artery spasm. Int Heart J 2010; 51: 211-213. PMID: 20558913 215. Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol (Oxf) 2017; 219: 22-96. PMID: 26706498 216. Sucato V, Novo G, Saladino A, et al. Coronary microvascular dysfunction. Minerva Cardioangiol 2020; 68: 153-163. PMID: 32083426 217. Kaski JC, Crea F, Gersh BJ, et al. Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris. Circulation 2018; 138: 1463- 1480. PMID: 30354347 218. Beltrame JF. Defining the coronary slow flow phenomenon. Circ J 2012; 76: 818-820. PMID: 22374148 219. Masi S, Rizzoni D, Taddei S, et al. Assessment and pathophysiology of microvascular disease: recent progress and clinical implications. Eur Heart J 2021; 42: 2590-2604. PMID: 33257973 220. Tsai SH, Lu G, Xu X, et al. Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy. Cardiovasc Res 2017; 113: 1329-1337. PMID: 28575410 221. Maseri A, Lanza GA. Angina pectoris caused by microvascular spasm. Lancet 1998; 352: 237-238. PMID: 9683241 222. Sun H, Fukumoto Y, Ito A, et al. Coronary microvascular dysfunction in patients with microvascular angina: Analysis by TIMI frame count. J Cardiovasc Pharmacol 2005; 46: 622-626. PMID: 16220069 223. Murakami H, Urabe K, Nishimura M. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X. J Am Coll Cardiol 1998; 32: 1287-1294. PMID: 9809938 224. Jansen TPJ, Elias-Smale SE, van den Oord S, et al. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease. Front Cardiovasc Med 2021; 8: 750071. PMID: 34722680 225. Masumoto A, Mohri M, Takeshita A. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. Int J Cardiol 2001; 81: 151-156. PMID: 11744131 226. Ong P, Pirozzolo G, Athanasiadis A, et al. Epicardial Coronary Spasm in Women With Angina Pectoris and Unobstructed Coronary Arteries Is Linked With a Positive Family History: An Observational Study. Clin Ther 2018; 40: 1584-1590. PMID: 30122309 227. Probst S, Seitz A, Martínez Pereyra V, et al. Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries. Eur Heart J Acute Cardiovasc Care 2021; 10: 380-387. PMID: 33609124 228. Suzuki S, Kaikita K, Yamamoto E, et al. Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease. Cardiovasc Interv Ther 2021; 36: 39-51. PMID: 33108592 229. Vidal-Perez R, Abou Jokh Casas C, Agra-Bermejo RM, et al. Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions. World J Cardiol 2019; 11: 305-315. PMID: 31908730 230. Pirozzolo G, Seitz A, Athanasiadis A, et al. Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA). Clin Res Cardiol 2020; 109: 246-254. PMID: 31236694 231. Lanza GA, Crea F. Primary coronary microvascular dysfunction: Clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317-2325. PMID: 20516386 232. Montone RA, Niccoli G, Russo M, et al. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries. Clin Res Cardiol 2020; 109: 435-443. PMID: 31270616 233. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/

ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69: 2212-2241. PMID: 28291663 234. Van’t Veer M, Pijls NHJ, Hennigan B, et al. Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? J Am Coll Cardiol 2017; 70: 3088-3096. PMID: 29268922 235. Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 1997; 95: 522-528. PMID: 9008472 236. Sueda S, Kohno H. Differential Incidence and Morphology of Spasm According to Coronary Arterial Location by Intracoronary Ergonovine Spasm Provocation Testing. Circ J 2017; 81: 831-836. PMID: 28331112 237. Sueda S, Sakaue T. Intracoronary ergonovine testing among 505 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease. Heart Vessels 2022; 37: 931-941. PMID: 35059807 238. Reis SE, Holubkov R, Lee JS, et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women’s Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999; 33: 1469-1475. PMID: 10334410 239. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: Superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 2006; 113: 2054-2061. PMID: 16636168 240. Ford TJ, Ong P, Sechtem U, et al. COVADIS Study Group. Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When. JACC Cardiovasc Interv 2020; 13: 1847-1864. PMID: 32819476 241. Fearon WF, Kobayashi Y. Invasive Assessment of the Coronary Microvasculature: The Index of Microcirculatory Resistance. Circ Cardiovasc Interv 2017; 10: e005361. PMID: 29222132 242. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-1824. PMID: 10334456 243. Phan A, Shufelt C, Merz CN. Persistent chest pain and no obstructive coronary artery disease. JAMA 2009; 301: 1468-1474. PMID: 19351944 244. Crea F, Bairey Merz CN, Beltrame JF, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J 2019; 40: 2455-2462. PMID: 30608528 245. Caramori PR, Lima VC, Seidelin PH, et al. Long-term endothelial dysfunction after coronary artery stenting. J Am Coll Cardiol 1999; 34: 1675-1679. PMID: 10577555 246. Fuke S, Maekawa K, Kawamoto K, et al. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007; 71: 220-225. PMID: 17251671 247. Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 166-170. PMID: 16249221 248. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46: 231-236. PMID: 16022947 249. Puricel S, Kallinikou Z, Espinola J, et al. Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT). Int J Cardiol 2016; 202: 525-531. PMID: 26440470 250. Ito S, Nakasuka K, Morimoto K, et al. Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation. J Invasive Cardiol 2011; 23: 57-64. PMID: 21297201 251. Mitsutake Y, Ueno T, Yokoyama S, et al. Coronary endothelial dys-